Richard Glickman

Richard Glickman discloses dealings in Eupraxia Pharmaceuticals Inc. to SEDI. We count 3 filings; the first trade dates from 18 August 2023 and the latest from 23 September 2025.

No open-market sale appears; the market trades are 2 purchases worth €17k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2025 to date brings 2 purchases and no sales.

On 30 September 2025 came the latest disclosure, an open-market purchase for €8,291 in Eupraxia Pharmaceuticals Inc. Typically, a trade is published a median of 7 days after it takes place. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.